Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Thomas

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cureus|November 18, 2024
Tracheobronchial Amyloidosis Causing Left Lung Collapse: A Case ReportRayhan Karimi, Arun Adlakha, Rob Thomas
BMC Cancer|July 20, 2022
ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs)Rohini Sharma, Susanna Slater, Joanne Evans, et al.
Nature Communications|April 25, 2015
Both respiration and photosynthesis determine the scaling of plankton metabolism in the oligotrophic oceanPablo Serret, Carol Robinson, María Aranguren-Gassis, et al.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Cancers|March 7, 2019
Rapid Induction of Liver Regeneration for Major Hepatectomy (REBIRTH): A Randomized Controlled Trial of Portal Vein Embolisation versus ALPPS Assisted with RadiofrequencyLong R Jiao, Ana B Fajardo Puerta, Tamara M H Gall, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2025
Evaluating the lifetime cumulative dose as a basis for carcinogenic potency of nitrosamines - a key tenet underpinning less-than-lifetime approaches for establishing acceptable intake limitsSusan P Felter, Ashley M Mudd, David J Ponting, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasiaQasim Ahmed, Nikolaos Doumanoglou, Joanne Evans, et al.
American Journal of Medical Genetics. Part A|September 21, 2021
Paternal retraction of a fragile X allele to normal size, showing normal function over two generationsEssra Bartlett, Alison D Archibald, David Francis, et al.
Regulatory Toxicology and Pharmacology : RTP|May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cureus|November 18, 2024
Tracheobronchial Amyloidosis Causing Left Lung Collapse: A Case ReportRayhan Karimi, Arun Adlakha, Rob Thomas
BMC Cancer|July 20, 2022
ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs)Rohini Sharma, Susanna Slater, Joanne Evans, et al.
Nature Communications|April 25, 2015
Both respiration and photosynthesis determine the scaling of plankton metabolism in the oligotrophic oceanPablo Serret, Carol Robinson, María Aranguren-Gassis, et al.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Cancers|March 7, 2019
Rapid Induction of Liver Regeneration for Major Hepatectomy (REBIRTH): A Randomized Controlled Trial of Portal Vein Embolisation versus ALPPS Assisted with RadiofrequencyLong R Jiao, Ana B Fajardo Puerta, Tamara M H Gall, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2025
Evaluating the lifetime cumulative dose as a basis for carcinogenic potency of nitrosamines - a key tenet underpinning less-than-lifetime approaches for establishing acceptable intake limitsSusan P Felter, Ashley M Mudd, David J Ponting, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasiaQasim Ahmed, Nikolaos Doumanoglou, Joanne Evans, et al.
American Journal of Medical Genetics. Part A|September 21, 2021
Paternal retraction of a fragile X allele to normal size, showing normal function over two generationsEssra Bartlett, Alison D Archibald, David Francis, et al.
Regulatory Toxicology and Pharmacology : RTP|May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Pageof 1